iRhythm Holdings Inc (IRTC)
Industry Medical Devices
This stock can be held in an Investment ISA and an Investment Account
Sell
$47.32
Buy
$118.12
$3.81 (+3.34%)
Prices updated at 31 Mar 2026, 21:32 EDT
| Prices minimum 15 mins delay
Prices in USD
iRhythm Technologies Inc is a commercial-stage digital healthcare company redefining the way cardiac arrhythmias are clinically diagnosed by combining wearable biosensing technology with cloud-based data analytics and machine-learning capabilities.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Sector
Healthcare
Industry
Medical Devices
Chairman
Mr. Abhijit Y. Talwalkar
CEO
Mr. Quentin S. Blackford
Most recent earnings
31 Dec 2025
Fiscal year end
31 Dec 2025
Employees
2,400
Head office
699 8th Street
San Francisco
United States
94103
Key personnel
Owner name | Salary |
|---|---|
Mr. Jason Patten Independent Director | - |
Mr. Abhijit Y. Talwalkar Chairman of the Board | 0.11m |
Ms. Karen K. McGinnis, C.P.A. Independent Director | - |
Mr. Bruce G. Bodaken Independent Director | 0.07m |
Ms. Karen L. Ling Independent Director | 0.07m |
Mr. Quentin S. Blackford Director, President and Chief Executive Officer | 0.74m |
Mr. Brian B. Yoor Independent Director | 0.06m |
Dr. Cathleen Noel Bairey Merz, M.D. Independent Director | 0.06m |
Mr. Kevin O’Boyle Independent Director | - |
Mr. Chad Patterson Chief Commercial Officer and Product Officer | 0.52m |
Mr. Daniel G. Wilson Chief Financial Officer | 0.46m |
Mr. Marc Rosenbaum Senior Vice President, Finance and Chief Accounting Officer | - |
Ms. Sumi Shrishrimal Executive Vice President and Chief Risk Officer | - |
Mr. Patrick M. Murphy Chief Business Officer and Chief Legal Officer | 0.51m |
Dr. Minang Turakhia, M.D.,M.S. Chief Medical Officer, Chief Scientific Officer and Executive Vice President, Product Innovation | 0.51m |
Mr. Mervin Smith Executive Vice President, Business Operations | - |
Top 5 shareholders
Owner name | No. of shares |
|---|---|
| Tudor Investment Corp Et AL | 20,000,000 |
| Vanguard Group Inc | 3,310,519 |
| BlackRock Inc | 2,875,476 |
| Sands Capital Management, LLC | 1,699,645 |
| Artisan Partners Limited Partnership | 1,511,992 |
Director dealings
Date | Action |
|---|---|
| 02 Dec 2025 | - |
| 28 Nov 2025 | - |
| 28 Nov 2025 | - |
| 28 Nov 2025 | - |
| 10 Nov 2025 | - |
| 10 Nov 2025 | - |
| 10 Nov 2025 | - |
| 10 Nov 2025 | - |
| 10 Nov 2025 | - |
| 10 Nov 2025 | - |
| 10 Nov 2025 | - |
| 10 Nov 2025 | - |
| 03 Nov 2025 | - |
| 31 Oct 2025 | - |
| 03 Sep 2025 | - |
| 02 Sep 2025 | - |
| 22 Aug 2025 | - |
| 11 Aug 2025 | - |
| 11 Aug 2025 | - |
| 11 Aug 2025 | - |
Please note that past performance is not a reliable indicator of future returns.
